Sheryl L. Windsor

Heart Failure / Cardiomyopathy

Saint Luke's Health System

About

Sheryl L. Windsor works in Heart Failure / Cardiomyopathy affiliated with Saint Luke's Health System.

Sheryl L. Windsor, BS, is affiliated with Saint Luke's Mid America Heart Institute at Saint Luke's Health System in Kansas City, Missouri. She has co-authored multiple peer-reviewed publications on SGLT2 inhibitors such as dapagliflozin in heart failure with preserved and reduced ejection fraction. Her research focuses on cardiovascular outcomes, biomarkers, and related topics in cardiology and endocrinology.

Research focus

SGLT2 inhibitors in heart failureHeart failure with preserved ejection fractionBiomarkers and symptoms in heart failureDiabetes and cardiovascular risk management

Impact

46 pubs · 3,544 cites · h-index 20

Affiliations

Work Experience

Researcher

Saint Luke's Mid America Heart Institute